Sue Bailey Net Worth & Insider Trades
Sue Bailey - Director, Emergent Biosolutions Inc
What is Sue Bailey's Net Worth?
The current estimated net worth of Emergent Biosolutions Inc's Director, Sue Bailey, is estimated to be about $6.39M . Sue Bailey owns about 24,427 units of Emergent Biosolutions Inc common stock. In the last 14 years at Emergent Biosolutions Inc, Sue Bailey has sold an estimated value of $6.01M worth.
What is Sue Bailey's Past Insider Trading?
Sue Bailey's largest purchase order was 17,717 units , worth over $289.16K on November 29, 2018. Sue Bailey's largest sale order was 17,717 units , worth over $1.23M on November 29, 2018. In total, Sue Bailey has made about 26 transactions over 14 years of their time at Emergent Biosolutions Inc. Sue Bailey usually trades in May, with the busiest year in 2020. The most recent transaction was a sale order of 8,168 units , worth over $754.48K on March 8, 2021.
Sue Bailey
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Sue Bailey's' Mailing Address?
- Mailing address is 400 Professional Drive Suite 400 Gaithersburg MD 20850 MD
Emergent Biosolutions Inc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Fuad El-Hibri | 2020 | $1,192,202 | $1,200,046 | $815,051 | - | $6,185 | $3,213,484 |
| Fuad El-Hibri | 2019 | $1,131,577 | $1,099,949 | $773,813 | - | $4,723 | $3,010,062 |
| Fuad El-Hibri | 2018 | $1,047,031 | $957,456 | $957,481 | - | $8,250 | $2,970,218 |
| Robert Kramer | 2020 | $893,860 | $2,050,007 | $1,392,416 | $1,225,020 | $8,675 | $5,569,978 |
| Robert Kramer | 2019 | $678,021 | $1,439,958 | $1,012,999 | $557,108 | $5,735 | $3,693,821 |
| Robert Kramer | 2018 | $549,047 | $649,930 | $649,980 | $538,807 | $8,983 | $2,396,747 |
| Richard Lindahl | 2020 | $549,390 | $749,998 | $509,425 | $462,012 | $10,475 | $2,281,300 |
| Richard Lindahl | 2019 | $514,826 | $619,984 | $436,154 | $297,429 | $9,104 | $1,877,497 |
| Richard Lindahl | 2018 | $365,393 | $557,438 | $351,101 | $330,007 | $8,514 | $1,612,453 |
| Adam Havey | 2020 | $546,507 | $700,047 | $475,413 | $445,204 | $8,357 | $2,175,528 |
| Adam Havey | 2019 | $484,120 | $619,984 | $436,154 | $279,579 | $25,530 | $1,845,367 |
| Adam Havey | 2018 | $480,728 | $499,974 | $359,784 | $310,212 | $8,383 | $1,659,081 |
| Atul Saran | 2020 | $528,803 | $700,047 | $475,413 | $445,204 | $9,565 | $2,159,032 |
| Atul Saran | 2019 | $503,774 | $619,984 | $436,154 | $293,567 | $9,500 | $1,862,979 |
| Atul Saran | 2018 | $488,730 | $527,475 | $379,572 | $293,567 | $8,683 | $1,698,027 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1367644/000136764421000061/ebsi2021asmproxystatement.htm
What are Emergent Biosolutions Inc's Past Insider Trades?
Emergent Biosolutions Inc's most recent insider trade came on November 29, 2022 by Richard S. Lindahl Attorney-In-Fact who sold 1,912 units worth $22.83K . In the last 16 years, insiders at Emergent Biosolutions Inc have sold an estimated value of $238.48M and bought an estimated value of $38.64M worth of shares. Insider trading is most common in May, with the busiest year in 2007. The most active traders at the company are Fuad Elhibri, Director, Daniel Abdunnabi, CEO, and Robert Kramer, President and CEO .
Emergent BioSolutions Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||